ABSTRACT
A mild ischemic stroke may cause both debilitating locomotor and cognitive decline, for which the mechanism is not fully understood, and no therapies are currently available. In this study, a nonfatal stroke model was constructed in mice by a modified middle cerebral artery occlusion (MCAO) procedure, allowing an extended recovery period up to 28 days. The extended MCAO model successfully mimicked phenotypes of a recovery phase post-stroke, including locomotor motor and cognitive deficiencies, which were effectively improved after Shuxuening injection (SXNI) treatment. Tissue slices staining showed that SXNI repaired brain injury and reduced neuronal apoptosis, especially in the hippocampus CA3 region. Transcriptomics sequencing study revealed 565 differentially expressed genes (DEGs) in the ischemic brain after SXNI treatment. Integrated network pharmacological analysis identified Neurotrophin/Trk Signaling was the most relevant pathway, which involves 15 key genes. Related DEGs were further validated by RT-PCR. Western-blot analysis showed that SXNI reversed the abnormal expression of BDNF, TrkB, Mek3 and Jnk1after stroke. ELISA found that SXNI increased brain level of p-Erk and Creb. At sub-brain level, the expression of BDNF and TrkB was decreased and GFAP was increased on the hippocampal CA3 region in the post-stroke recovery phase and this abnormality was improved by SXNI. In vitro experiments also found that oxygen glucose deprivation reduced the expression of BDNF and TrkB, which was reversed by SXNI. In summary, we conclude that SXNI facilitates the recovery of cognitive and locomotor dysfunction by modulating Neurotrophin/Trk Signaling in a mouse model for the recovery phase of post-ischemic stroke.
Subject(s)
Brain-Derived Neurotrophic Factor/drug effects , Cognition Disorders/drug therapy , Cognition Disorders/etiology , Drugs, Chinese Herbal/therapeutic use , Hippocampus/metabolism , Movement Disorders/drug therapy , Movement Disorders/etiology , Nerve Growth Factors/drug effects , Receptor, trkA/drug effects , Signal Transduction/drug effects , Stroke Rehabilitation/methods , Stroke/complications , Animals , Cell Line , Drugs, Chinese Herbal/administration & dosage , Gene Expression Regulation/drug effects , Male , Mice , Mice, Inbred C57BL , Psychomotor Performance/drug effects , Recovery of Function , Stroke/psychology , TranscriptomeABSTRACT
Dehydroepiandrosterone (DHEA) is the most abundant circulating steroid hormone in humans, produced by the adrenals, the gonads and the brain. DHEA was previously shown to bind to the nerve growth factor receptor, tropomyosin-related kinase A (TrkA), and to thereby exert neuroprotective effects. Here we show that DHEA reduces microglia-mediated inflammation in an acute lipopolysaccharide-induced neuro-inflammation model in mice and in cultured microglia in vitro. DHEA regulates microglial inflammatory responses through phosphorylation of TrkA and subsequent activation of a pathway involving Akt1/Akt2 and cAMP response element-binding protein. The latter induces the expression of the histone 3 lysine 27 (H3K27) demethylase Jumonji d3 (Jmjd3), which thereby controls the expression of inflammation-related genes and microglial polarization. Together, our data indicate that DHEA-activated TrkA signaling is a potent regulator of microglia-mediated inflammation in a Jmjd3-dependent manner, thereby providing the platform for potential future therapeutic interventions in neuro-inflammatory pathologies.
Subject(s)
Dehydroepiandrosterone/pharmacology , Inflammation/metabolism , Microglia/drug effects , Animals , CREB-Binding Protein/metabolism , Jumonji Domain-Containing Histone Demethylases/metabolism , Lipopolysaccharides/pharmacology , Male , Mice , Mice, Inbred C57BL , Neuroprotective Agents/pharmacology , Phosphorylation , Proto-Oncogene Proteins c-akt/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Receptor, trkA/drug effects , Receptors, Nerve Growth Factor/drug effects , Signal Transduction/drug effectsABSTRACT
The binding of the human nerve growth factor (NGF) protein to tropomyosin receptor kinase A (TrkA) is associated with Alzhemeir's development. Owing to the large presence of zinc(II) ions in the synaptic compartments, the zinc ions might be bound to the complex in vivo. Here, we have identified a putative zinc binding site using a combination of computations and experiments. First, we have predicted structural features of the NGF/TrkA complex in an aqueous solution by molecular simulation. Metadynamics free energy calculations suggest that these are very similar to those in the X-ray structure. Here, the "crab" structure of the NGF shape binds tightly to two TrkA "pincers". Transient conformations of the complex include both more extended and more closed conformations. Interestingly, the latter features facial histidines (His60 and His61) among the N-terminal D1-D3 domains, each of which is a potential binding region for biometals. This suggests the presence of a four-His Zn binding site connecting the two chains. To address this issue, we investigated the binding of a D1-D3 domains' peptide mimic by stability constant and nuclear magnetic resonance measurements, complemented by density functional theory-based calculations. Taken together, these establish unambiguously a four-His coordination of the metal ion in the model systems, supporting the presence of our postulated binding site in the NGF/TrkA complex.
Subject(s)
Molecular Conformation/drug effects , Nerve Growth Factor/metabolism , Tropomyosin/pharmacology , Zinc/metabolism , Humans , Nerve Growth Factor/drug effects , Neurogenesis/drug effects , Protein Binding/drug effects , Protein Kinases/metabolism , Receptor, trkA/drug effects , Receptor, trkA/metabolismABSTRACT
BACKGROUND: Pyrrolizidine alkaloids (PAs) are commonly found in many plants including those used in medical therapeutics. The hepatotoxicities of PAs have been demonstrated both in vivo and in vitro; however, the neurotoxicities of PAs are rarely mentioned. PURPOSE: In this study, we aimed to investigate in vitro neurotoxicities of clivorine, one of the PAs found in various Ligularia species, in cultured PC12 cells. STUDY DESIGN: PC12 cell line was employed to first elucidate the neurotoxicity and the underlying mechanism of clivorine, including cell viability and morphology change, neuronal differentiation marker and signaling pathway. METHODS: PC12 cells were challenged with series concentrations of clivorine and/or nerve growth factor (NGF). The cell lysates were collected for MTT assay, trypan blue staining, immunocytofluorescent staining, qRT-PCR and western blotting. RESULTS: Clivorine inhibited cell proliferation and neuronal differentiation evidenced by MTT assay and dose-dependently reducing neurite outgrowth, respectively. In addition, clivorine decreased the level of mRNAs encoding for neuronal differentiation markers, e.g. neurofilaments and TrkA (NGF receptor). Furthermore, clivorine reduced the NGF-induced the phosphorylations of TrkA, protein kinase B and cAMP response element-binding protein in cultured PC12 cells. CONCLUSION: Taken together, our results suggest that clivorine might possess neurotoxicities in PC12 cells via down-regulating the NGF/TrkA/Akt signaling pathway. PAs not only damage the liver, but also possess neurotoxicities, which could possibly result in brain disorders, such as depression.
Subject(s)
Asteraceae/chemistry , Nerve Growth Factor/pharmacology , Neurons/drug effects , Pyrrolizidine Alkaloids/pharmacology , Signal Transduction/drug effects , Animals , Cell Differentiation/drug effects , Cell Survival/drug effects , Dose-Response Relationship, Drug , Oncogene Protein v-akt/drug effects , PC12 Cells , Phosphorylation , Rats , Receptor, trkA/drug effectsABSTRACT
Tricyclic antidepressant amitriptyline (AM) has been shown to exert neurotrophic activity on neurons. We thus explored whether AM may aid the neuronal development and protect anesthesia-induced neuro-injury in young spinal cord dorsal root ganglion (DRG) neurons.The DRG explants were prepared from 1-day-old rats. The effect of AM on aiding DRG neural development was examined by immunohistochemistry at dose-dependent manner. AM-induced changes in gene and protein expressions, and also phosphorylation states of tyrosine kinases receptor A (TrkA) and B (TrkB) in DRG, were examined by quantitative real-time polymerase chain reaction and western blot. The effect of AM on attenuating lidocaine-induced DRG neurodegeneration was examined by immunohistochemistry, and small interfering RNA (siRNA)-mediated TrkA/B down-regulation.Amitriptyline stimulated DRG neuronal development in dose-dependent manner, but exerted toxic effect at concentrations higher than 10âM. AM activated TrkA in DRG through phosphorylation, whereas it had little effect on TrkB-signaling pathway. AM reduced lidocaine-induced DRG neurodegeneration by regenerating neurites and growth cones. Moreover, the neuroprotection of AM on lidocaine-injured neurodegeneration was blocked by siRNA-mediated TrkA down-regulation, but not by TrkB down-regulation.Amitriptyline facilitated neuronal development and had protective effect on lidocaine-induced neurodegeneration, very likely through the activation of TrkA-signaling pathway in DRG.
Subject(s)
Amitriptyline/pharmacology , Anesthetics, Local/adverse effects , Antidepressive Agents, Tricyclic/pharmacology , Ganglia, Spinal/drug effects , Lidocaine/adverse effects , Nerve Degeneration/chemically induced , Receptor, trkA/drug effects , Animals , Cells, Cultured , Dose-Response Relationship, Drug , Ganglia, Spinal/growth & development , Rats , Real-Time Polymerase Chain Reaction , Receptor, trkA/physiology , Receptor, trkB/drug effects , Receptor, trkB/physiologyABSTRACT
Clioquinol is considered to be a causative agent of subacute myelo-optico neuropathy (SMON), although the pathogenesis of SMON is yet to be elucidated. We have previously shown that clioquinol inhibits nerve growth factor (NGF)-induced Trk autophosphorylation in PC12 cells transformed with human Trk cDNA. To explore the further mechanism of neuronal damage by clioquinol, we evaluated the acetylation status of histones in PC12 cells. Clioquinol reduced the level of histone acetylation, and the histone deacetylase (HDAC) inhibitor Trichostatin A upregulated acetylated histones and prevented the neuronal cell damage caused by clioquinol. In addition, treatment with HDAC inhibitor decreased neurite retraction and restored the inhibition of NGF-induced Trk autophosphorylation by clioquinol. Thus, clioquinol induced neuronal cell death via deacetylation of histones, and HDAC inhibitor alleviates the neurotoxicity of clioquinol. Clioquinol is now used as a potential medicine for malignancies and neurodegenerative diseases. Therefore, HDAC inhibitors can be used as a candidate medicine for the prevention of its side effects on neuronal cells.
Subject(s)
Clioquinol/toxicity , Histone Deacetylase Inhibitors/pharmacology , Histones/metabolism , Hydroxamic Acids/toxicity , Neurons/drug effects , Neuroprotective Agents/pharmacology , Acetylation , Animals , Cell Death/drug effects , Cell Shape/drug effects , Cytoprotection , Humans , Neurons/enzymology , Neurons/pathology , PC12 Cells , Phosphorylation , Rats , Receptor, trkA/drug effects , Receptor, trkA/genetics , Receptor, trkA/metabolism , Signal Transduction/drug effects , Time Factors , TransfectionABSTRACT
In this study, we evaluated, in the mouse, the effects of 20 mg/kg i.p. daily administration for 15 consecutive days of a blend of polyphenols, containing mostly oleuropein, extracted from the olive leaves (Olea europaea) on brain nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) and on the expression of their receptors, TrkA, TrkB and p75. Polyphenols decreased the levels of reduced glutathione (GSH) and increased the levels of NGF and BDNF in the serum. In the brain, we found decreased levels of NGF and BDNF in the hippocampus and striatum but elevated levels of NGF in the olfactory lobes and hypothalamus and again BDNF potentiation in the olfactory lobes. No changes in TrkA, TrkB and p75 expression were observed. In conclusion, olive polyphenols may not only elicit an activation of the rodent olfactory system by increasing the levels of NGF and BDNF but also be stressing for the animal by reducing both the levels of hippocampal NGF/BDNF and serum GSH and increasing serum levels of NGF and BDNF.
Subject(s)
Brain-Derived Neurotrophic Factor/drug effects , Olea/chemistry , Polyphenols/pharmacology , Receptor, trkA/drug effects , Receptor, trkB/drug effects , Receptors, Nerve Growth Factor/drug effects , Animals , Blotting, Western , Brain/metabolism , Glutathione/analysis , Glutathione/blood , Glutathione/drug effects , Iridoid Glucosides , Iridoids/administration & dosage , Iridoids/pharmacology , Male , Mice , Models, Animal , Nerve Growth Factor/drug effects , Nerve Growth Factors/pharmacology , Neurons/drug effects , Plant Leaves/chemistry , Polyphenols/administration & dosageABSTRACT
p75(NTR) is a neurotrophin receptor that can mediate either survival or death of neurons depending on the cell context. Modulation of p75(NTR) is a promising strategy to promote neuronal survival for treatment of cognitive disorders such as Alzheimer's disease. Despite years of investigation into the signaling mechanisms of p75(NTR), no p75(NTR) signaling assay has yet been developed that is compatible with efficient screening of small-molecule modulators. In this work, we developed a homogeneous cell-based assay for screening p75(NTR) modulators and studying p75(NTR) function. Stimulation of p75(NTR)-transfected cells using either nerve growth factor (NGF) or Pro-NGF resulted in an enhanced caspase-3 activity as assessed by cleavage of a fluorescent caspase-3 substrate. Optimization of the assay with respect to time, cell density, NGF and Pro-NGF concentration, and other factors provided a twofold increase in the caspase-3 activity compared to background. Withdrawal of serum during the NGF or Pro-NGF treatment period was found to be essential for p75(NTR)-dependent caspase-3 activation. We validated the method by demonstrating that a signaling-incompetent p75(NTR) mutant could not substitute for wild-type p75(NTR) in mediating caspase-3 activation. A focused library screen identified new inhibitors of p75(NTR) signaling. This method will be useful for identifying small-molecule modulators of p75(NTR) as well as further characterizing downstream signaling events.
Subject(s)
Caspase 3/drug effects , Drug Evaluation, Preclinical/methods , Enzyme Activation/drug effects , Nerve Tissue Proteins/physiology , Receptors, Nerve Growth Factor/physiology , Signal Transduction/drug effects , Animals , Cell Survival/drug effects , Fluorescent Antibody Technique , HEK293 Cells , Humans , Microscopy, Fluorescence , Nerve Growth Factor/pharmacology , Rats , Receptor, trkA/drug effects , Small Molecule Libraries , TransfectionABSTRACT
AIM: To investigate the effect of Ad-ING4 on proliferation and migration of glioma cells and explore its probable mechanism. METHODS: U251 were infected with Ad-ING4. ING4 gene expression was evaluated by RT-PCR. MTT assay was adopted to evaluate the effect of ING4 on proliferation of U251; Boyden chamber assay was used to check the effect of ING4 on the migration of U251. In ING4 transfected U251, Western blot was used for detecting NGF and TrkA expression; Pull-down assay was used for detecting active RhoA expression. RESULTS: ING4 was overexpressed in Ad-ING4 transfected U251 cells. ING4 inhibited proliferation and migration of U251 significantly. Moreover, overexpression of ING4 result in depression of NGF, TrkA and active RhoA. CONCLUSION: ING4 mediated inhibition of the proliferation and migration of human glioma cells by down regulating NGF, TrkA and active RhoA expression.
Subject(s)
Cell Cycle Proteins/metabolism , Central Nervous System Neoplasms/metabolism , Central Nervous System Neoplasms/pathology , Glioma/metabolism , Glioma/pathology , Homeodomain Proteins/metabolism , Receptor, trkA/metabolism , Tumor Suppressor Proteins/metabolism , rhoA GTP-Binding Protein/metabolism , Cell Cycle Proteins/pharmacology , Cell Line, Tumor , Cell Movement/drug effects , Cell Movement/physiology , Cell Proliferation/drug effects , Down-Regulation , Homeodomain Proteins/pharmacology , Humans , Nerve Growth Factor/drug effects , Nerve Growth Factor/metabolism , Receptor, trkA/drug effects , Transfection , Tumor Suppressor Proteins/pharmacology , rhoA GTP-Binding Protein/drug effectsABSTRACT
Apolipoprotein E (apoE) is one of the major transporters of cholesterol in the body and is essential for maintaining various neural functions in the brain. Given that hypercholesterolemia is a risk factor in Alzheimer's disease (AD), it has been suggested that altered cholesterol metabolism may be involved in the development of the pathogenesis, including neural degeneration, commonly observed in AD patients. Neurotrophic factors and their receptors, which are known to regulate various neural functions, are also known to be altered in various neurodegenerative diseases. We therefore hypothesized that cholesterol metabolism may itself influence the neurotrophin system within the brain. We decided to investigate this possibility by modulating the amount of dietary cholesterol given to apoE-knockout (apoE-KO) and wild-type (WT) mice, and examining the mRNA expression of various neurotrophin ligands and receptors in their hippocampal formations. Groups of eight-week-old apoE-KO and WT mice were fed a diet containing either "high" (HCD) or "normal" (ND) levels of cholesterol for a period of 12 weeks. We found that high dietary cholesterol intake elevated BDNF mRNA expression in both apoE-KO and WT mice and TrkB mRNA expression in apoE-KO animals. On the other hand, NGF and TrkA mRNA levels remained unchanged irrespective of both diet and mouse type. These findings indicate that altered cholesterol metabolism induced by HCD ingestion combined with apoE deficiency can elicit a differential response in the various neurotrophin ligand/receptor systems in the mouse hippocampus. Whether such changes can lead to neural degeneration, and the mechanisms that may be involved in this, awaits further research.
Subject(s)
Apolipoproteins E/deficiency , Brain-Derived Neurotrophic Factor , Cholesterol, Dietary , Hippocampus/metabolism , Receptor, trkB , Alzheimer Disease/metabolism , Animals , Brain-Derived Neurotrophic Factor/drug effects , Brain-Derived Neurotrophic Factor/metabolism , Cholesterol, Dietary/adverse effects , Cholesterol, Dietary/metabolism , Humans , Hypercholesterolemia/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Growth Factor/drug effects , Nerve Growth Factor/metabolism , RNA, Messenger/metabolism , Receptor, trkA/drug effects , Receptor, trkA/metabolism , Receptor, trkB/drug effects , Receptor, trkB/metabolismABSTRACT
Brain-derived neurotrophic factor (BDNF) is closely linked with neuronal survival and plasticity in psychiatric disorders. In this work, we engineered degradable, injectable alginate microspheres and non-degradable, implantable poly(ethylene vinyl acetate) matrices to continuously deliver BDNF to the dorsal hippocampus of rats for two days or more than a week, respectively. The antidepressant-like behavioral effects of BDNF delivery were examined in the Porsolt forced swim test. Rats were sacrificed 10days after surgery and tissue samples were analyzed by western blot. A small dose of BDNF delivered in a single infusion, or from a two-day sustained-release alginate implant, produced an antidepressant-like behavior, whereas the same dose delivered over a longer period of time to a larger tissue region did not produce antidepressant-like effects. Prolonged delivery of BDNF resulted in a dysregulation of plasticity-related functions: increased dose and duration of BDNF delivery produced increased levels of TrkB, ERK, CREB, and phosphorylated ERK, while also producing decreased phosphorylated CREB. It is evident from this work that both duration and magnitude of BDNF dosing are of critical importance in achieving functional outcome.
Subject(s)
Antidepressive Agents/administration & dosage , Brain-Derived Neurotrophic Factor/administration & dosage , Depression/prevention & control , Drug Delivery Systems/methods , Hippocampus/drug effects , Alginates/administration & dosage , Animals , Behavior, Animal/drug effects , Biocompatible Materials/administration & dosage , Blotting, Western , Cyclic AMP Response Element-Binding Protein/drug effects , Drug Carriers/administration & dosage , Extracellular Signal-Regulated MAP Kinases/drug effects , Glucuronic Acid/administration & dosage , Hexuronic Acids/administration & dosage , Male , Microspheres , Neuronal Plasticity/drug effects , Polyvinyls/administration & dosage , Rats , Rats, Sprague-Dawley , Receptor, trkA/drug effects , Receptor, trkA/metabolism , Stress, Psychological/prevention & controlABSTRACT
A conditioning lesion improves regeneration of central and peripheral axons of dorsal root ganglion (DRG) neurons after a subsequent injury by enhancing intrinsic growth capacity. This enhanced growth state is also observed in cultured DRG neurons, which support a more sparsely and rapidly elongating mode of growth after a prior conditioning lesion in vivo. Here we examined differences in the capacity or requirements of specific types of sensory neurons for regenerative growth, which has important consequences for development of strategies to improve recovery after injury. We showed that after partial or complete injury of the sciatic nerve in mice, an elongating mode of growth in vitro was activated only in DRG neurons that did not express calcitonin gene-related peptide (CGRP) or bind Bandeiraea simplicifolia I-isolectin B4 (IB4). We also directly examined the response of conditioned sensory neurons to nerve growth factor (NGF), which does not enhance growth in injured peripheral nerves in vivo. We showed that after partial injury, NGF stimulated a highly branched and linearly restricted rather than elongating mode of growth. After complete injury, the function of NGF was impaired, which immunohistochemical studies of DRG indicated was at least partly due to downregulation of the NGF receptor, tropomyosin-related kinase A (TrkA). These results suggest that, regardless of the type of conditioning lesion, each type of DRG neuron has a distinct intrinsic capacity or requirement for the activation of rapidly elongating growth, which does not appear to be influenced by NGF.
Subject(s)
Calcitonin Gene-Related Peptide/metabolism , Ganglia, Spinal/metabolism , Nerve Regeneration/physiology , Peripheral Nerves/metabolism , Sciatic Neuropathy/metabolism , Sensory Receptor Cells/metabolism , Animals , Calcitonin Gene-Related Peptide/genetics , Cells, Cultured , Denervation , Ganglia, Spinal/cytology , Ganglia, Spinal/drug effects , Ganglia, Spinal/injuries , Growth Cones/drug effects , Growth Cones/metabolism , Growth Cones/ultrastructure , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Nerve Growth Factor/metabolism , Nerve Growth Factor/pharmacology , Nerve Regeneration/drug effects , Peripheral Nerve Injuries , Peripheral Nerves/cytology , Peripheral Nerves/drug effects , Plant Lectins/metabolism , Receptor, trkA/drug effects , Receptor, trkA/metabolism , Recovery of Function/physiology , Sciatic Neuropathy/genetics , Sciatic Neuropathy/physiopathology , Sensory Receptor Cells/cytology , Sensory Receptor Cells/drug effects , Signal Transduction/drug effects , Signal Transduction/physiology , Staining and LabelingABSTRACT
Neurotrophins and their receptors are known to play a role in the proliferation and survival of many different cell types of neuronal and non-neuronal lineages. In addition, there is much evidence in the literature showing that the p75 neurotrophin receptor (p75(NTR)), alone or in association with members of the family of Trk receptors, is expressed in a wide variety of stem cells, although its role in such cells has not been completely elucidated. In the present work we have investigated the expression of p75(NTR) and Trks in totipotent and pluripotent cells, the mouse pre-implantation embryo and embryonic stem and germ cells (ES and EG cells). p75(NTR) and TrkA can be first detected in the blastocyst from which ES cell lines are derived. Mouse ES cells retain p75(NTR)/TrkA expression. Nerve growth factor is the only neurotrophin able to stimulate ES cell growth in culture, without affecting the expression of stem cell markers, alkaline phosphatase, Oct4 and Nanog. Such proliferation effect was blocked by antagonizing either p75(NTR) or TrkA. Interestingly, immunoreactivity to anti-p75(NTR) antibodies is lost upon ES cell differentiation. The expression pattern of neurotrophin receptors in murine ES cells differs from human ES cells, that only express TrkB and C, and do not respond to NGF. In this paper we also show that, while primordial germ cells (PGC) do not express p75(NTR), when they are made to revert to an ES-like phenotype, becoming EG cells, expression of p75(NTR) is turned on.
Subject(s)
Embryonic Stem Cells/metabolism , Receptor, Nerve Growth Factor/metabolism , Receptor, trkA/metabolism , Alkaline Phosphatase/metabolism , Animals , Apoptosis/drug effects , Apoptosis/physiology , Cell Line , Cell Proliferation/drug effects , DNA Fragmentation/drug effects , Embryonic Stem Cells/cytology , Embryonic Stem Cells/drug effects , Homeodomain Proteins/metabolism , Mice , Nanog Homeobox Protein , Nerve Growth Factor/pharmacology , Octamer Transcription Factor-3/metabolism , Receptor, Nerve Growth Factor/drug effects , Receptor, trkA/drug effectsABSTRACT
BACKGROUND: Nerve growth factor (NGF) is an important mediator of airway hyper-responsiveness and hyperalgesia but its role in cough is unknown. OBJECTIVES: In this study the effects of NGF on the cough reflex and airway calibre were investigated in guinea pigs. The involvement of the tropomyosin-related kinase A (TrkA) receptor and transient receptor potential vanilloid-1 (TRPV1), and the p38 mitogen-activated protein kinase (MAPK)-dependent pathway in any NGF-induced effects on cough and airway obstruction was also assessed. METHODS: Guinea pigs were placed in a transparent whole-body plethysmograph box. Cough was assessed visually, acoustically and by analysis of the airflow signal. Airway obstruction was measured using enhanced pause (Penh) as an index. RESULTS: Exposure of guinea pigs to NGF did not induce a cough response nor a significant airway obstruction. However, exposure of guinea pigs to NGF immediately before citric acid inhalation resulted in a significant increase in the citric acid-induced cough and airway obstruction compared with vehicle-treated animals. Pretreatment with the TrkA receptor antagonist, K252a, or the TRPV1 antagonist, iodoresiniferatoxin, significantly inhibited the NGF-enhanced cough and airway obstruction. Exposure to NGF also increased p38 MAPK phosphorylation, but pretreatment with the p38 MAPK inhibitor, SB203580, did not affect either the NGF-enhanced cough or airway obstruction despite preventing the NGF-induced elevation in p38 MAPK phosphorylation. CONCLUSIONS: The data show that NGF can enhance both cough and airway obstruction via a mechanism that involves the activation of the TrkA receptor and TRPV1 but not the p38 MAPK-dependent pathway.
Subject(s)
Airway Obstruction/metabolism , Cough/metabolism , Nerve Growth Factors/pharmacology , Receptor, trkA/drug effects , TRPV Cation Channels/drug effects , Airway Obstruction/chemically induced , Animals , Carbazoles/pharmacology , Citric Acid , Cough/chemically induced , Diterpenes/pharmacokinetics , Enzyme Inhibitors/pharmacology , Female , Guinea Pigs , Imidazoles/pharmacology , Indole Alkaloids/pharmacology , Male , Phosphorylation , Pyridines/pharmacology , Receptor, trkA/antagonists & inhibitors , Receptor, trkA/metabolism , TRPV Cation Channels/antagonists & inhibitors , TRPV Cation Channels/metabolism , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/metabolismABSTRACT
In this study, possible involvements of choline and nicotinic acetylcholine receptors (nAChRs) in neurotrophic-related neuronal plasticity were investigated. Primary cell cultures from rat cerebral cortex were exposed for 72 h to the alpha7 nAChR selective agonist choline and protein expression levels of the neurotrophin receptors p75, TrkA, TrkB and TrkC were examined. The results revealed a choline-induced attenuation of the TrkB expression, whereas the other neurotrophin receptors were not affected. Further analysis of choline-exposed cell cultures showed an increased protein level of the TrkB ligand brain-derived neurotrophic factor (BDNF). This increase was obtained in cell cultures where the alpha7 nAChR subunit was detected, but not in younger cell cultures where this subunit could not be detected. It is speculated that a choline-induced change of alpha7 nAChRs activity may have resulted in the observed increase of BDNF level and down-regulation of the TrkB receptor.
Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Cerebral Cortex/metabolism , Choline/metabolism , Neuronal Plasticity/physiology , Receptor, trkB/metabolism , Receptors, Nicotinic/metabolism , Animals , Cells, Cultured , Cerebral Cortex/cytology , Choline/pharmacology , Down-Regulation/physiology , Nerve Tissue Proteins , Neuronal Plasticity/drug effects , Nicotinic Agonists/metabolism , Nicotinic Agonists/pharmacology , Rats , Receptor, trkA/drug effects , Receptor, trkA/metabolism , Receptors, Growth Factor , Receptors, Nerve Growth Factor/drug effects , Receptors, Nerve Growth Factor/metabolism , Receptors, Nicotinic/drug effects , Signal Transduction/drug effects , Signal Transduction/physiology , Up-Regulation/physiology , alpha7 Nicotinic Acetylcholine ReceptorSubject(s)
Analgesics , Antibodies, Monoclonal , Pain/drug therapy , Analgesics/administration & dosage , Analgesics/pharmacology , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/pharmacology , Drug Discovery , Humans , Nerve Growth Factor/immunology , Receptor, trkA/drug effects , Sodium Channels/drug effects , TRPV Cation Channels/antagonists & inhibitorsABSTRACT
Laminin-1, an extracellular matrix molecule, promotes neurite outgrowth through the interaction of integrin and actin. Monosialoganglioside GM1 in the lipid rafts associates with and activates the NGF receptor TrkA, and enhances neurite outgrowth. However, the role of GM1 in laminin-1-induced neurite outgrowth was still unclear. Here, we describe that laminin-1 binds to GM1 through a carbohydrate moiety and a specific conformation of GM1, induces focal formation of large clusters of GM1, and enhances the relocation of TrkA in the membrane of dorsal root ganglion (DRG) and PC12 cells. We found that laminin-1-mediated clustering of GM1 causes the translocation and enrichment of beta1 integrin in lipid rafts--where TrkA colocalizes with beta1 integrin--and the activation of Lyn, Akt and MAPK to promote the outgrowth of neurites. Our results suggest that the binding of laminin-1 to GM1 facilitates the formation of a focal microdomain in the membrane, and enhances signal transduction that promotes neurite outgrowth by linking NGF-TrkA signaling with the laminin-integrin signaling pathways.
Subject(s)
G(M1) Ganglioside/metabolism , Integrin beta1/metabolism , Laminin/metabolism , Membrane Microdomains/metabolism , Nerve Growth Factor/pharmacology , Neurites/physiology , Receptor, trkA/metabolism , Animals , Cell Line , Enzyme Inhibitors/pharmacology , G(M1) Ganglioside/analogs & derivatives , Integrin beta1/drug effects , Laminin/pharmacology , Mice , Microscopy, Immunoelectron , Neurites/drug effects , Neurites/ultrastructure , Pyrazoles/pharmacology , Pyrimidines/pharmacology , Rats , Receptor, trkA/drug effects , Signal Transduction/physiology , src-Family Kinases/drug effects , src-Family Kinases/metabolismABSTRACT
BACKGROUND: To date, no effective therapeutic treatment prevents prostate cancer (PCa) progression to more advanced and invasive disease forms. It has been demonstrated that the simultaneous high expression of p185(HER2) and TrkA might confer a proliferative advantage to PCa cells. METHODS: In this work we verified the crosstalk between TrkA and Her2 signaling pathways and the effects of a combined treatment with Her2 and TrkA inhibitors. RESULTS: NGF induced TrkA activation and stimulated cell proliferation of PCa cells. NGF induced also tyrosine phosphorylation of p185(HER2). This event was only partially inhibited by the pan Trk inhibitor, CEP-701 but was strongly blocked by pertuzumab, a humanized antibody blocking Her2 heterodimerization. In presence of NGF, TrkA and Her2 co-precipitated and this was dependent to the relative high cellular levels of TrkA since when cell lysates were immunoprecipitated with an antibody against Her2 the amount of TrkA were proportional to the cellular levels of this receptor. On the contrary when we immunoprecipitated using an antibody against TrkA the amount of Her2 seemed independent to cellular levels of Her2. So, combined treatment between CEP-701 and pertuzumab showed supra-additive effects in cells with higher levels of TrkA and Her2 suggesting once again that this was indicative of a higher response to treatment. CONCLUSIONS: Our data suggest that the dual inhibition of TrkA and Her2 may be useful in a subset of patients in which TrkA and Her2 are overexpressed and in which the possibility of TrkA and Her2 protein-binding is elevated.
Subject(s)
Antibodies, Monoclonal/therapeutic use , Carbazoles/therapeutic use , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/metabolism , Receptor Cross-Talk/physiology , Receptor, ErbB-2/metabolism , Receptor, trkA/metabolism , Animals , Antibodies, Monoclonal/pharmacology , Antibodies, Monoclonal, Humanized , Carbazoles/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Drug Therapy, Combination , Furans , Male , Mice , Nerve Growth Factor/pharmacology , Prostatic Neoplasms/pathology , Receptor Cross-Talk/drug effects , Receptor, ErbB-2/drug effects , Receptor, trkA/drug effects , Receptors, Androgen/drug effects , Xenograft Model Antitumor AssaysABSTRACT
Misdirection of axons after nerve injury impairs successful regeneration of adult neurons. Investigations of axon guidance in development have provided an understanding of pathfinding, but their relevance to regenerating adult axons is unclear. We investigated adult mammalian axon guidance during regeneration after peripheral nerve injury and focused on the effects of the prototypic guidance molecule nerve growth factor (NGF). Adult rat sensory neurons from dorsal root ganglia that expressed the NGF receptor tropomyosin-related kinase A (trkA) were presented with a point source of NGF in vitro. Naive trkA neurons had no net turning response to NGF, but if they had been preconditioned by a peripheral nerve transection in vivo before culturing, their growth cones were attracted toward the NGF gradient. A laminin substrate was required for this behavior and an anti-trkA antibody interrupted turning. These data demonstrate that injured adult mammalian axons can be guided as they regenerate. Moreover, despite the downregulation of trkA mRNA and protein levels within the dorsal root ganglion after injury, sensory neurons retain and increase trkA protein at the injury site where the regenerating axons are found. This may enhance the axonal response to NGF and allow guidance along an NGF gradient created in vivo in the distal nerve stump.